These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 25656249

  • 21. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S, Noble A, Deslandres C.
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [Abstract] [Full Text] [Related]

  • 23. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Vasudevan A, Raghunath A, Anthony S, Scanlon C, Sparrow MP, Gibson PR, van Langenberg DR.
    Dig Dis Sci; 2019 Jun; 64(6):1622-1631. PubMed ID: 30560332
    [Abstract] [Full Text] [Related]

  • 24. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
    Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV.
    World J Gastroenterol; 2014 Jul 21; 20(27):9185-90. PubMed ID: 25083093
    [Abstract] [Full Text] [Related]

  • 25. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B, Lubov J, Theoret Y, Afif W, Bitton A, Wild G, Lakatos PL, Bessissow T.
    Dig Dis Sci; 2021 May 21; 66(5):1650-1657. PubMed ID: 32591969
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study.
    Park J, Chun J, Park SJ, Park JJ, Kim TI, Yoon H, Cheon JH.
    Dig Dis Sci; 2024 Mar 21; 69(3):901-910. PubMed ID: 38217678
    [Abstract] [Full Text] [Related]

  • 27. Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
    Colman RJ, Rubin DT.
    J Crohns Colitis; 2015 Apr 21; 9(4):312-7. PubMed ID: 25616487
    [Abstract] [Full Text] [Related]

  • 28. [A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy].
    Choi JR, Yun GW, Park YM, Kim JH, Youn YH, Park HJ, Park JJ.
    Korean J Gastroenterol; 2015 Oct 21; 66(4):231-6. PubMed ID: 26493510
    [Abstract] [Full Text] [Related]

  • 29. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z, Chao K, Li M, Zhi M, Tang J, Hu P, Gao X.
    Inflamm Bowel Dis; 2017 Mar 21; 23(3):440-447. PubMed ID: 28129286
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
    Mesonero F, Castro-Poceiro J, Benítez JM, Camps B, Iborra M, López-García A, Torres P, Esteve M, Tosca J, Bertoletti F, Almela P, Calvet X, Vera I, Bujanda L, Gomollón F, Rodríguez C, Antolín B, Busquets D, Hernández A, Rivero M, Monfort I Miquel D, Castaño-García A, Gisbert JP, Domènech E, López-Sanromán A, ENEIDA Project of GETECCU.
    Aliment Pharmacol Ther; 2021 May 21; 53(9):1021-1029. PubMed ID: 33715177
    [Abstract] [Full Text] [Related]

  • 31. [The efficacy and safety of methotrexate in refractory Crohn's disease].
    Xu P, He Y, Chen Y, Chao K, Chen B, Mao R, Tang R, Zhu Z, Zeng Z, Chen M.
    Zhonghua Nei Ke Za Zhi; 2014 Mar 21; 53(3):188-92. PubMed ID: 24767205
    [Abstract] [Full Text] [Related]

  • 32. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lémann M.
    Gastroenterol Clin Biol; 2002 Jan 21; 26(1):17-22. PubMed ID: 11938035
    [Abstract] [Full Text] [Related]

  • 33. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L.
    J Crohns Colitis; 2016 Jan 21; 10(1):55-60. PubMed ID: 26520164
    [Abstract] [Full Text] [Related]

  • 34. Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Fischer M, Campbell SC, Calley CSJ, Helper DJ, Chiorean MV, Fadda HM.
    Dig Dis Sci; 2017 Nov 21; 62(11):3131-3137. PubMed ID: 28986660
    [Abstract] [Full Text] [Related]

  • 35. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S, Nakase H, Matsuura M, Masuda S, Inui K, Chiba T.
    J Clin Gastroenterol; 2011 Jul 21; 45(6):526-30. PubMed ID: 21336140
    [Abstract] [Full Text] [Related]

  • 36. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease.
    Ranjan MK, Vuyyuru SK, Kante B, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V.
    Int J Colorectal Dis; 2022 Aug 21; 37(8):1817-1826. PubMed ID: 35835862
    [Abstract] [Full Text] [Related]

  • 37. Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.
    Hausmann J, Zabel K, Herrmann E, Schröder O.
    Inflamm Bowel Dis; 2010 Jul 21; 16(7):1195-202. PubMed ID: 19924799
    [Abstract] [Full Text] [Related]

  • 38. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.
    Digestion; 2017 Nov 21; 96(4):220-227. PubMed ID: 29065423
    [Abstract] [Full Text] [Related]

  • 39. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
    Salazar J, Garcia-Planella E, Fernández-Clotet A, Esteve M, Gisbert JP, Busquets D, Lucendo A, Márquez L, Guardiola J, Martín-Arranz MD, Iglesias E, Monfort D, Villoria A, Cañete F, Bell O, Ricart E, Zabana Y, Chaparro M, Domènech E, Gordillo J, ENEIDA registry of GETECCU.
    Br J Clin Pharmacol; 2024 May 21; 90(5):1301-1311. PubMed ID: 38369687
    [Abstract] [Full Text] [Related]

  • 40. Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies.
    Martín-de-Carpi J, Pociello N, Varea V.
    J Crohns Colitis; 2010 Nov 21; 4(5):594-8. PubMed ID: 21122566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.